Status: current, Defined. Date: 31-Oct 2021. Module: Australian Medicines Terminology module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 4632311000168116 | Crysvita (burosumab 20 mg / 1 mL) injection, 1 x 1 mL vial (trade product pack) | en | Fully specified name | Active | Case sensitive | Australian Medicines Terminology module |
| 4632321000168111 | Crysvita 20 mg/mL injection, 1 mL vial | en | Synonym | Active | Case sensitive | Australian Medicines Terminology module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Crysvita 20 mg/mL injection, 1 mL vial | Is a | burosumab 20 mg/mL injection, 1 mL vial | true | Inferred relationship | Some | ||
| Crysvita 20 mg/mL injection, 1 mL vial | Is a | trade product pack | true | Inferred relationship | Some | ||
| Crysvita 20 mg/mL injection, 1 mL vial | has TP | Crysvita | true | Inferred relationship | Some | ||
| Crysvita 20 mg/mL injection, 1 mL vial | has TPUU | Crysvita 20 mg/mL injection, 1 mL vial | true | Inferred relationship | Some | 1150829732 |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Crysvita 20 mg/mL injection, 1 mL vial | Is a | True | Crysvita 20 mg/mL injection, 1 mL vial | Inferred relationship | Some |
Reference Sets
Trade product pack reference set
FHIR